Sony partners with Vueling to bring boarding passes to SmartWatch 2

by XB on 20th March 2014

in Accessories, Applications

Vueling SmartWatch Boarding PassSony will launch what it claims is the world’s first wearable boarding pass through the SmartWatch 2. Sony has partnered with Vueling to make this happen. Boarding passes on your phone are quite common nowadays, but moving that to your wrist delivers an extra layer of convenience, especially with bags in tow. A new exclusive app will be launched on the Google Play Store at the end of March. It will use a 2D barcode to put the flight information and boarding passes on your wrist.

Vueling SmartWatch Boarding Pass

Via Sony Mobile Blog.

Thanks Rene!

  • Mirrorpurple

    Seems nice

  • Pingback: Sony SmartWatch 2 Gets Boarding Passes With Veuling Airlines()

  • neekoo1234

    I hope they will reduce the price of smw2 from $199 to $150

  • sony1

    nice to meet you :D

  • hansip

    Will Sony create a rounded smartwatch? Or at least, a thin bezel square smartwatch with soft keys, or maybe some knob like buttons? That would be nice, and oh yeah, an NFC on the front face will help to connect the phone with, say, a new Bluetooth accessories, where the instruction will be transmitted from smartwatch to the phone. Or some tap payment.. That would be useful :)

  • Guest

    Let the android wear come by LG and Moto it wont even dare to appear close to them lol!!

  • Raj Singh

    This will be useful for those who use the SmartWatch2.
    Sidenote: Android Wear will force manufacturers to consider other form factors and come out with different designs, such as the Moto 360, which looks very cool.

  • fried_egg

    Even though I have had to have my SW2 replaced because of the lifting screen problem, I still love it.

  • Hamza Salau

    this just reminds me that i can’t wait till the moto 360 comes out

  • Rene Pedroso

    Got mine free with my XZ1

  • Yang Lin

    Abstract: Objective evaluation of tigecycline ( tetracycline antibiotic ) in vitro antibacterial activity against clinical strains . Methods broth dilution method for tigecycline and other 14 kinds of drugs for nearly two years in the hospital clinical specimens of 400 bacteria were isolated MIC determined by WHONET5.4 statistical software . The results showed that MIC determination : tigecycline against methicillin-resistant Staphylococcus aureus (MRSA) and Enterococcus showed good antibacterial activity in vitro test has three vancomycin-resistant enterococci (VRE), on behalf of tigecycline and linezolid -sensitive display ;Daptomycin? against Gram- negative bacteria Escherichia coli and ESBL-producing Klebsiella spp MIC ? are 1trg · mL ~, behind or below meropenem ; present study for tigecycline against Acinetobacter baumannii

    The MIC. (2trg · mL a ) a minimum in all tests of antimicrobial drugs ; against Pseudomonas aeruginosa MIC ? value of 16p. g · mL ~.Tigecycline hydrochloride? Conclusion tigecycline against clinical pathogens have good broad-spectrum antimicrobial activity against Pseudomonas aeruginosa Yin poor antibacterial activity.

    Tigecycline (tigecycline) is a derivative of minocycline , is the first clinical application of new glycyl doxycycline antibiotics . Intravenous drug formulations, in 2005 the U.S. Food and Drug Administration (FDA) approval : tigecycline for the treatment of patients aged 18 and older infections caused by susceptible strains , indications include : complicated intra-abdominal infections ( such as complicated appendicitis ,Tigecycline mesylate? burns infections, intra-abdominal abscesses, deep soft tissue infections and infected ulcers ) and complicated skin and soft tissue infections. The drug can overcome the limitations of many two main resistance mechanisms of antimicrobial drug use : efflux pumps and ribosomal protection. 1 shows a lot of old literature : the drug can be used to treat multi-drug resistant , such as MRSA, VRE, producing extended-spectrum 13 -lactamase bacterial infections caused by Enterobacteriaceae .Ofloxacin
    To understand the in vitro antibacterial activity of the drug , the trial of the 2009 and 2010 clinical isolates from the Ministry of Health, Beijing Hospital, 400 clinical MIC common bacteria were measured to evaluate the in vitro antibacterial activity of the drug .

    Medchemexpress Can provide the above product,its website:

  • Divya Bharathi

    Very interesting thing I just come across at – I could choose any number of items (from the list) at very heavy discount rates (up to 75% off online) – more we buy more discount – I never seen this before.

  • Pingback: The Hobbit Xperia Theme released by Sony | The Today Online()

Previous post:

Next post: